Clinical Trials Browser

Phase 1 × OTHER_GOV × Recurrence × Clear all

NCT03881761 2019-03-21

CD19/20 Bispecific Nanobody-derived CAR-T Cells in B Cell Lymphoma

Phase 1 Unknown

Recurrence, Lymphoma, B-Cell

NCT03881774 2019-03-21

Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell

NCT03540303 2018-05-30

Cytoplasmic Activated PD-1 CAR T Cells in Refractory/Relapsed B Cell Lymphoma

Phase 1 Unknown

Lymphoma, Lymphoma, Non-Hodgkin, Recurrence